Abstract
Background The gut microbiome modulates human brain function and eating behavior through multiple factors, including short-chain fatty acid (SCFA) signaling. We aimed to explore which bacterial genera relate to eating behavior, diet and SCFA metabolites in overweight adults. In addition, we tested whether eating-related microbiota relate to treatment success in patients after Roux-en-Y gastric bypass (RYGB).
Methods Anthropometrics, dietary fibre intake, eating behaviour, 16S-rRNA-derived microbiota and SCFA measured in feces and blood were correlated in young overweight adults (n=27 (9F), 21-36 years, BMI 25-31 kg/m2). Correlated genera were compared in RYGB (n=23 (16F), 41-70 years, BMI 25-62 kg/m2) and in control patients (n=17 (11F), 26-69 years, BMI 25-48 kg/m2).
Results In young adults, 7 bacteria genera, i.e. Alistipes, Blautia, Clostridiales cluster XVIII, Gemmiger, Roseburia, Ruminococcus and Streptococcus, correlated with healthier eating behavior, while 5 genera, i.e. Clostridiales cluster IV and XIVb, Collinsella, Fusicatenibacter and Parabacteroides, correlated with unhealthier eating (all |r| > 0.4, FDR-corrected p < 0.05). Some of these genera including Parabacteroides related to fiber intake and SCFA metabolites, and to weight status and treatment response in overweight/obese patients.
Conclusions Specific bacterial genera, particularly Parabacteroides, were associated with weight status and eating behavior in two independent well-characterized cross-sectional samples. These exploratory findings indicate two groups of presumably beneficial and unfavourable genera that relate to eating behaviour and weight status, and indicate that dietary fiber and SCFA metabolism may modify these relationships.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03829189
Funding Statement
This work was supported by grants of the German Research Foundation, contract grant number CRC 1052 Obesity mechanisms, project number 209933838, subprojects A1 (AV), A5 (AH), AOBJ: 624808 (WF), WI 3342/3-1 (AVW), IFB AdiposityDiseases FKZ: 01EO1501 (AH, WF), by the Else Kroener-Fresenius Foundation (WF), by the German Federal Environmental Foundation (EM) and by the Max Planck Society.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
institutional ethics board of the Medical Faculty of the University of Leipzig sample 1: 228/18-ek sample 2: 027/17-ek
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data relevant to the study are included in the article or uploaded as supplementary information.
